JOURNAL ARTICLE
RESEARCH SUPPORT, N.I.H., EXTRAMURAL
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Postoperative opioid consumption and its relationship to cognitive function in older adults with hip fracture.

OBJECTIVES: To determine the relationship between opioid consumption and cognitive impairment after hip fracture repair.

DESIGN: Prospective study of consecutive patients.

SETTING: Johns Hopkins Bayview Medical Center, Baltimore, Maryland.

PARTICIPANTS: Two hundred thirty-six participants aged 65 and older undergoing hip fracture repair.

MEASUREMENTS: Older adults without preoperative delirium who underwent hip fracture repair between April 2005 and July 2009 were followed for pain, opioid consumption, and postoperative delirium. Participants were tested for delirium using the Confusion Assessment Method preoperatively and midmorning on Postoperative Day 2. The nursing staff assessed pain on a numeric oral scale (range 0-10). Opioid analgesia was provided in response to pain at rest to achieve scores of 3 or less. Opioid consumption was analyzed with respect to the occurrence of incident postoperative delirium, presence of dementia, and other demographic variables.

RESULTS: Of the 236 participants, 66 (28%) had dementia, and 213 (90%) received opioids postoperatively, including 55 (83%) with dementia and 158 (93%) without. There was no association between the use of any postoperative opioid and incident delirium (P = .61) in participants with (P = .33) and without (P = .40) dementia. Dementia, but not postoperative delirium, was associated with less opioid use (P < .001 for dementia; P = .12 for delirium; P = .04, for their interaction; Wald chi-square = 142.8, df = 7). Opioid dose (P ≥ .59) on Postoperative Days 1 and 2 was not predictive of incident delirium. Dementia (P < .001) and intensive care unit admission (P = .006), not opioid consumption, were the most important predictors of incident postoperative delirium.

CONCLUSION: Concern for postoperative delirium should not prevent the use of opioid analgesic therapy sufficient to achieve a generally accepted level of comfort in individuals with or without preexisting cognitive impairment.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app